A comparison of the pharmacokinetics of two dosing regimens of cisapride and their effects on corrected QT interval in premature infants

European Journal of Clinical Pharmacology

Volumn 59, Issue 1, 2003, Pages 17-22

  Cools, Filip ^a   Benatar, Avram ^a   Bruneel, Els ^b   Theyskens, Claire ^b   Bougatef, Adel ^a   Casteels, Ann ^a   Vandenplas, Yvan ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b DEPARTMENT OF CARDIOLOGY   (Belgium)

Author keywords

Cisapride; Pharmacokinetics; QTc interval

Indexed keywords

CISAPRIDE;

ARTICLE; BIRTH; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG TRANSFORMATION; ELECTROCARDIOGRAM; GESTATIONAL AGE; HEART ARRHYTHMIA; HEART REPOLARIZATION; HUMAN; INFANT; NEWBORN INTENSIVE CARE; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL; QT INTERVAL; REGRESSION ANALYSIS;

EID: 0038130966     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-003-0582-6     Document Type: Article

References (14)

1. Committee on Safety of Medicines/Medicines Control Agency (1998) Cisapride (Prepulsid): risk of arrhythmias. Curr Probl Pharmacovigilance 24:11
2. Craig JS, Tubman TRJ, McClure BG (1998) Survey of cisapride usage in preterm infants in UK and Ireland. Pediatr Res 44:425
3. Gheuens J (2000) http://www.janssen.com/cacPro/Pro_Lim_Ac_DDL.htm
4. Ferriman A (2000) UK licence for cisapriide suspended. BMJ 321:259
5. Cools F, Benatar A, Bougatef A, Vandenplas Y (2001) The effect of cisapride on the corrected QT interval and QT dispersion in premature infants. J Pediatr Gastroenterol Nutr 33:178-181
6. Benatar A, Feenstra A, Decraene T, Vandenplas Y (2000) Effects of cisapride on corrected QT interval, heart rate, and rhythm in infants undergoing polysomnography. Pediatrics 106:E85
7. Benatar A, Feenstra A, Decraene T, Vandenplas Y (2000) Cisapride plasma levels and corrected QT interval in infants undergoing routine polysomnography. J Pediatr Gastroenterol Nutr 33:41-46
8. Benatar A, Ramet J, Decraene T, Vandenplas Y (2002) QT interval in normal infants during sleep with concurrent evaluation of QT correction formulae. Med Sci Monit 8:351-356
9. Meulderman W, Van Peer A, Hendrickx J et al (1988) Excretion and biotransformation of cisapride in dogs and humans after oral administration. Drug Metab Dispos 16:403-409
10. Lacroix D, Sonnier M, Moncion A, Cheron G, Cresteil T (1997) Expression of CYP3A in human liver: evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 247:625-634
11. c prolongation in very low birth weight preterm infants. Pediatrics 107:1313-1316
12. Drolet B, Khalifa M, Daleau P, Hamelin BA, Turgeon J (1998) Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval. Circulation 97:204-210
13. Gintant GA, Limberis JT, McDermott JS, Wegner CD, CoxBF (2001) The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis. J Cardiovasc Pharmacol 37:607-618
14. Preechagoon Y, Charles B, Piotrovskij V, Donovan T, Van Peer A (1999) Population pharmacokinetics of enterally administered cisapride in young infants with gastro-oesophageal reflux disease. J Clin Pharmacol 48:688-693